<DOC>
	<DOCNO>NCT02945683</DOCNO>
	<brief_summary>The purpose study evaluate randomize , double-blinded , controlled trial , whether new food supplement contain Lactobacillus reuteri DSM 17938 vitamin D3 ( ReuterinÂ® D3 ) may improve SCORAD pediatric patient mild moderate atopic dermatitis</brief_summary>
	<brief_title>Effects Lactobacillus Reuteri Plus Vitamin D3 Children With Atopic Dermatitis</brief_title>
	<detailed_description>Recent evidence suggest childhood allergy development link imbalance intestinal microbiota . The probiotic bacteria , contribute balance intestinal microflora , may play key role modulation immune response , look potential resource prevention treatment allergic disorder . In study investigator recruit pediatric patient atopic dermatitis mild-to-moderate degree , standard treatment consist use emollient cream topical steroid case exacerbation . The investigator assume participant receive significant benefit addition standard treatment food supplement contain L. reuteri DSM 17938 vitamin D3 , , thanks beneficial effect intestinal microbiota modulation immune response , may compensate inadequate capacity patient produce antimicrobial peptide response cutaneous aggression , improve , therefore , severity disease . 88 child sex , 1 4 year old , SCORAD 25-50 select part routine outpatient visit Pediatric Allergy Department University Hospital Verona . The study product ( active placebo ) administer 3 month , follow-up period 3 month . From participant , time 0 3 month , blood stool sample collect analysis vitamin D cathelicidin level analysis microflora respectively .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>diagnosis atopic dermatitis mild moderate grade ( SCORAD 2550 ) signature inform consent parent legal representative presence autoimmune disease , immunodeficiency , inflammatory bowel disease , cystic fibrosis , metabolic disease use immunosuppressive drug and/or systemic corticosteroid previous 2 month use antibiotic last 4 week use probiotic and/or prebiotics last 2 week use vitamin D last 4 week participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>atopic dermatitis , probiotic , vitamin D3 , L. reuteri</keyword>
</DOC>